| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −100.0% | |
| Gross profit | 0.0 | 0.0 | 0.0 | (0.0) | (0.0) | 0.0 | +100.0% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.9 | 1.1 | 1.6 | 0.7 | 0.6 | 2.8 | +371.2% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 0.9 | 1.0 | 1.0 | 1.6 | 6.2 | 2.8 | −55.3% | |
| Operating income | (0.9) | (1.0) | (1.6) | (1.6) | (6.2) | (2.8) | +55.4% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.4 | +515.2% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −65.0% | |
| Other income / expense | (0.0) | (0.0) | 0.0 | 0.0 | (0.0) | (1.7) | −3577.6% | |
| Pre-tax income | (1.0) | (1.0) | (1.6) | (1.6) | (6.2) | (4.5) | +28.6% | |
| Income tax | 0.0 | (0.0) | (0.1) | 0.0 | 0.0 | 0.0 | +25.0% | |
| Net income | (1.0) | (1.0) | (1.5) | (1.5) | (6.2) | (4.5) | +28.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.02) | (0.01) | (0.01) | (0.01) | (0.04) | (0.02) | +46.6% | |
| EPS, diluted (per share) | (0.02) | (0.01) | (0.01) | (0.01) | (0.04) | (0.02) | +46.6% | |
| EBITDA | (0.9) | (1.0) | (1.6) | (1.6) | (6.2) | (2.8) | +55.3% | |
| Depreciation & amortization | 0.2 | 0.0 | 0.0 | (0.0) | 1.6 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 57,527,529 | 104,213,499 | 121,794,101 | 123,483,143 | 169,554,296 | 226,448,558 | +33.6% | |
| Weighted average diluted shares (shares) | 57,527,529 | 104,213,499 | 121,794,101 | 123,483,143 | 169,554,296 | 226,448,558 | +33.6% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in GBP.